Aim: Although numerous animal studies suggest that probiotic therapy has beneficial effects in various liver diseases, the evidence for beneficial effects in human liver disease is controversial. This study was carried out to investigate the efficacy of probiotic therapy in alleviating small intestinal bacterial overgrowth (SIBO) and permeability in chronic liver disease. Methods: Fifty-three patients with chronic liver disease were randomized to either probiotic therapy or placebo. Six bacterial species were used: Bifidobacterium bifidum, Bifidobacterium lactis, Bifidobacterium longum, Lactobacillus acidophilus, Lactobacillus rhamnosus, and Streptococcus thermophilus. After 4 weeks, changes in the composition of fecal bacteria, SIBO, intes...
Context: Non-alcoholic fatty liver disease (NAFLD) is a chronic liver disease, with 5-10 % of liver ...
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
Context: Non-alcoholic fatty liver disease (NAFLD) is a chronic liver disease, with 5-10 % of liver ...
Aim: Although numerous animal studies suggest that probiotic therapy has beneficial effects in vario...
Aim: Although numerous animal studies suggest that probiotic therapy has beneficial effects in vario...
Aim: Although numerous animal studies suggest that probiotic therapy has beneficial effects in vario...
AIM:: Although numerous animal studies suggest that probiotic therapy has beneficial effects in vari...
Background: This study was conducted to investigate the effi - cacy of probiotics administration in ...
Background: This study was conducted to investigate the effi - cacy of probiotics administration in ...
Intestinal microbiota plays an important role in health and disease. Alteration in its healthy homeo...
The prevalence of non-alcoholic fatty liver disease (NAFLD) has soared globally. As our understandin...
The prevalence of non-alcoholic fatty liver disease (NAFLD) has soared globally. As our understandin...
Background. Emerging evidence suggests a strong interaction between the gut, gut microbiota and live...
Background: The gut–liver axis has many implications in non-alcoholic fatty liver disease onset as t...
During the last two decades, non-alcoholic fatty liver disease (NAFLD) has been a topic in many disc...
Context: Non-alcoholic fatty liver disease (NAFLD) is a chronic liver disease, with 5-10 % of liver ...
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
Context: Non-alcoholic fatty liver disease (NAFLD) is a chronic liver disease, with 5-10 % of liver ...
Aim: Although numerous animal studies suggest that probiotic therapy has beneficial effects in vario...
Aim: Although numerous animal studies suggest that probiotic therapy has beneficial effects in vario...
Aim: Although numerous animal studies suggest that probiotic therapy has beneficial effects in vario...
AIM:: Although numerous animal studies suggest that probiotic therapy has beneficial effects in vari...
Background: This study was conducted to investigate the effi - cacy of probiotics administration in ...
Background: This study was conducted to investigate the effi - cacy of probiotics administration in ...
Intestinal microbiota plays an important role in health and disease. Alteration in its healthy homeo...
The prevalence of non-alcoholic fatty liver disease (NAFLD) has soared globally. As our understandin...
The prevalence of non-alcoholic fatty liver disease (NAFLD) has soared globally. As our understandin...
Background. Emerging evidence suggests a strong interaction between the gut, gut microbiota and live...
Background: The gut–liver axis has many implications in non-alcoholic fatty liver disease onset as t...
During the last two decades, non-alcoholic fatty liver disease (NAFLD) has been a topic in many disc...
Context: Non-alcoholic fatty liver disease (NAFLD) is a chronic liver disease, with 5-10 % of liver ...
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
Context: Non-alcoholic fatty liver disease (NAFLD) is a chronic liver disease, with 5-10 % of liver ...